Toxta 100UI — High-Purity Botulinum Toxin Type A

Toxta 100UI is a botulinum toxin type A product manufactured by JETEMA Co. in South Korea, built on an original Clostridium botulinum strain sourced from the European National Institute. It carries KFDA approval, and production follows cGMP standards recognized by the FDA and EMA.

Toxta reaches high purity with a low protein content, which helps reduce the risk of patients developing immune resistance over repeated treatments. Because of this, it suits both new patients and those continuing an established treatment plan.

• High purity, low immunogenicity: low protein content reduces the risk of resistance developing over time
• cGMP-compliant manufacturing: production follows standards recognized by the FDA and EMA
• Natural-looking results: smooths wrinkles without a frozen appearance
• Broad application range: suits facial wrinkle correction, masseter treatment, and hyperhidrosis

Packaging and included accessories vary by supplier — check your specific listing for exact kit contents.

Toxta blocks nerve impulse transmission at the neuromuscular junction, disrupting the release of acetylcholine. Once injected into a muscle, that muscle can no longer contract as forcefully. This helps wrinkles caused by repeated movement relax and soften, while also helping prevent new ones from forming.

Toxta arrives as a fine, freeze-dried powder that must be diluted with 0.9% saline before use. Because the powder is so fine, the vial can look nearly empty — this is normal, and the full 100-unit dose is present.

1. Remove the vial from the refrigerator and inspect it — it should be colorless and transparent, with a small quantity of white or light yellow powder visible
2. Draw the saline into a sterile syringe and slowly add it to the vial
3. Gently swirl to mix — do not shake
4. Inject within 24 hours of reconstitution, storing any unused mixture refrigerated at 2–8°C

• Forehead lines and glabellar lines (frown lines)
• Crow’s feet
• Laugh lines around the mouth and nose
• Neck creases and wrinkles
• Masseter muscle (jaw clenching, teeth grinding, and jawline contouring)
• Facial imbalances caused by muscle contractions
• Hyperhidrosis (excessive sweating)

For glabellar lines, a standard protocol dilutes the vial to 4 units per 0.1mL, then uses a 30G needle to inject 0.1mL per point across 5 sites in the corrugator and procerus muscles, for a total of 20 units. Toxta is also commonly used for masseter injections to manage teeth grinding and jaw clenching while contouring the jaw shape.

A qualified practitioner should determine dosing for other treatment areas based on the patient’s anatomy.

• For use by licensed medical professionals only
• Contraindicated in patients with neuromuscular junction disorders
• Contraindicated during pregnancy or breastfeeding
• Avoid in patients with active infection at the injection site
• Rare cases of distant toxin spread have been reported; always aspirate before injection and maintain emergency airway equipment on hand

• Store refrigerated at 2–8°C
• Do not freeze
• Protect from light
• Use within 24 hours after reconstitution

Botulinum toxin type A is a prescription medical product for use by licensed healthcare professionals only.

What is Toxta 100UI?
Toxta 100UI is a high-purity botulinum toxin type A product from JETEMA, used for facial wrinkle correction, masseter treatment, and hyperhidrosis.

Why does the vial look nearly empty?
Toxta’s freeze-dried powder is very fine, so little is visible at the bottom of the vial. The full 100-unit dose is present and dissolves completely once reconstituted.

How long do results last?
Results generally appear within 5 to 14 days and last up to 4 months, though this varies by treatment area and individual patient factors.

Can Toxta be used for jaw slimming?
Yes. Injected into the masseter muscle, Toxta helps manage teeth grinding and jaw clenching while contouring the shape of the jaw.